RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus

John T. O’Brien(North Tyneside General Hospital), Alison J. Yarnall(Newcastle upon Tyne Hospitals NHS Foundation Trust), Caroline H. Williams‐Gray(University of Cambridge), Rosie Watson, Leonidas Chouliaras(University of Cambridge), Afina W. Lemstra(Amsterdam Neuroscience), К. Ray Chaudhuri(NIHR Maudsley Dementia Biomedical Research Unit), Clive Ballard(University of Exeter), Daniel Weintraub(California University of Pennsylvania), Howard Feldman(University of British Columbia), Leon Flicker(The University of Western Australia), David J. Brooks(Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Dag Aarsland(King's College London), James B. Leverenz(University of Washington), Pietro Tiraboschi(Mayo Clinic in Florida), Donald G. Grosset(University of Glasgow), Jeffrey L. Cummings(University of California, Los Angeles), Richard T. Oakley(University of Waterloo), Marwan Sabbagh(Newcastle Hospitals - Campus for Ageing and Vitality), Jill Richardson(GlaxoSmithKline (United Kingdom)), Bradley F. Boeve(Mayo Clinic in Arizona), Manabu Ikeda(The University of Osaka), Brian Lawlor(Trinity College Dublin), Janet Sultana(University of Messina), Rimona S. Weil(University College London), Elisabet Londos(Lund University), Simon J.G. Lewis(The University of Sydney), Iracema Leroi(Trinity College Dublin), Susan Kohlhaas, Zuzana Walker(South Essex Partnership University Foundation NHS Trust), Per Svennigsson, John Skidmore, John‐Paul Taylor(School of the Art Institute of Chicago), James E. Galvin(School of the Art Institute of Chicago), Ian G. McKeith(Newcastle Hospitals - Campus for Ageing and Vitality), Frédéric Blanc, Roger Mills(King's College London)
Alzheimer s Research & Therapy
November 11, 2022
Cited by 17


Related Papers